light chain phosphorylation is a determinant of Ca 2ϩ sensitivity of force and activation dependence of the kinetics of myocardial force development. Am J Physiol Heart Circ Physiol 287: H2712-H2718, 2004. First published August 26, 2004; doi:10.1152/ajpheart.01067.2003.-It is generally recognized that ventricular myosin regulatory light chains (RLC) are ϳ40% phosphorylated under basal conditions, and there is little change in RLC phosphorylation with agonist stimulation of myocardium or altered stimulation frequency. To establish the functional consequences of basal RLC phosphorylation in the heart, we measured mechanical properties of rat skinned trabeculae in which ϳ7% or ϳ58% of total RLC was phosphorylated. The protocol for achieving ϳ7% phosphorylation of RLC involved isolating trabeculae in the presence of 2,3-butanedione monoxime (BDM) to dephosphorylate RLC from its baseline level. Subsequent phosphorylation to ϳ58% of total was achieved by incubating BDM-treated trabeculae in solution containing smooth muscle myosin light chain kinase, calmodulin, and Ca 2ϩ (i.e., MLCK treatment). After MLCK treatment, Ca 2ϩ sensitivity of force increased by 0.06 pCa units and maximum force increased by 5%. The rate constant of force development (k tr) increased as a function of Ca 2ϩ concentration in the range between pCa 5.8 and pCa 4.5. When expressed versus pCa, the activation dependence of k tr appeared to be unaffected by MLCK treatment; however, when activation was expressed in terms of isometric forcegenerating capability (as a fraction of maximum), MLCK treatment slowed k tr at submaximal activations. These results suggest that basal phosphorylation of RLC plays a role in setting the kinetics of force development and Ca 2ϩ sensitivity of force in cardiac muscle. Our results also argue that changes in RLC phosphorylation in the range examined here influence actin-myosin interaction kinetics differently in heart muscle than was previously reported for skeletal muscle. kinetics of force development; skinned myocardium MYOSIN REGULATORY LIGHT CHAIN (RLC), a thick filament protein associated with the neck region of the myosin molecule, belongs to the superfamily of EF-hand Ca 2ϩ -binding proteins, which includes troponin C (TnC) and calmodulin (CaM) (25). In mammalian muscles, RLC is phosphorylated by Ca 2ϩ /CaM-dependent myosin light chain kinase (MLCK) and dephosphorylated by light chain phosphatase (1). In smooth muscle, phosphorylation of RLC is necessary for force production, and the amount of force is related to the level of phosphorylation (16, 40) . In skeletal and cardiac muscles, RLC phosphorylation appears to modulate contraction, whereas Ca 2ϩ binding to the regulatory site on TnC is the regulatory switch that activates force production (33). Previous studies have shown that MLCKinduced phosphorylation of RLC 1) increases Ca 2ϩ sensitivity of force in both skinned skeletal (24, 42, 44) and cardiac muscles (8, 29, 30, 41) ; 2) increases the rate constant of force redevelopment (k tr ) in skinned skeletal muscle at low levels of activation (24, 42); and 3) eliminates force-dependent changes in the rate constant of relaxation in skinned skeletal muscle (37). Furthermore, in cardiac muscle, increases in Ca 2ϩ sensitivity of force after treatment with agonists for ␣ 1 -adrenoreceptors or endothelin receptors are thought to be mediated by increased phosphorylation of RLC (2, 39).
To establish the functional consequences of basal RLC phosphorylation in the heart, we measured mechanical properties of rat skinned trabeculae in which ϳ7% or ϳ58% of total RLC was phosphorylated. The protocol for achieving ϳ7% phosphorylation of RLC involved isolating trabeculae in the presence of 2,3-butanedione monoxime (BDM) to dephosphorylate RLC from its baseline level. Subsequent phosphorylation to ϳ58% of total was achieved by incubating BDM-treated trabeculae in solution containing smooth muscle myosin light chain kinase, calmodulin, and Ca 2ϩ (i.e., MLCK treatment). After MLCK treatment, Ca 2ϩ sensitivity of force increased by 0.06 pCa units and maximum force increased by 5%. The rate constant of force development (k tr) increased as a function of Ca 2ϩ concentration in the range between pCa 5.8 and pCa 4.5. When expressed versus pCa, the activation dependence of k tr appeared to be unaffected by MLCK treatment; however, when activation was expressed in terms of isometric forcegenerating capability (as a fraction of maximum), MLCK treatment slowed k tr at submaximal activations. These results suggest that basal phosphorylation of RLC plays a role in setting the kinetics of force development and Ca 2ϩ sensitivity of force in cardiac muscle. Our results also argue that changes in RLC phosphorylation in the range examined here influence actin-myosin interaction kinetics differently in heart muscle than was previously reported for skeletal muscle.
kinetics of force development; skinned myocardium MYOSIN REGULATORY LIGHT CHAIN (RLC), a thick filament protein associated with the neck region of the myosin molecule, belongs to the superfamily of EF-hand Ca 2ϩ -binding proteins, which includes troponin C (TnC) and calmodulin (CaM) (25) . In mammalian muscles, RLC is phosphorylated by Ca 2ϩ /CaM-dependent myosin light chain kinase (MLCK) and dephosphorylated by light chain phosphatase (1) . In smooth muscle, phosphorylation of RLC is necessary for force production, and the amount of force is related to the level of phosphorylation (16, 40) . In skeletal and cardiac muscles, RLC phosphorylation appears to modulate contraction, whereas Ca 2ϩ binding to the regulatory site on TnC is the regulatory switch that activates force production (33) . Previous studies have shown that MLCKinduced phosphorylation of RLC 1) increases Ca 2ϩ sensitivity of force in both skinned skeletal (24, 42, 44) and cardiac muscles (8, 29, 30, 41) ; 2) increases the rate constant of force redevelopment (k tr ) in skinned skeletal muscle at low levels of activation (24, 42) ; and 3) eliminates force-dependent changes in the rate constant of relaxation in skinned skeletal muscle (37) . Furthermore, in cardiac muscle, increases in Ca 2ϩ sensitivity of force after treatment with agonists for ␣ 1 -adrenoreceptors or endothelin receptors are thought to be mediated by increased phosphorylation of RLC (2, 39) .
Under normal physiological conditions, the antagonistic actions of MLCK and RLC phosphatase result in nearsteady phosphorylation of 30 -40% of total RLC in human (26) , pig (32) , and rat (12, 31) ventricular myocardium. Because RLC phosphorylation is known to increase Ca 2ϩ sensitivity of force and k tr in skeletal muscle, we hypothesized that the basal phosphorylation of RLC in myocardium contributes to baseline force and k tr in myocardium. To test this idea, we examined the Ca 2ϩ dependencies of force and k tr in rat skinned trabeculae treated with 2,3-butanedione monoxime (BDM) to dephosphorylate RLC (to ϳ7% of total RLC) and then treated them with MLCK to restore phosphorylation to ϳ58% of total RLC.
MATERIALS AND METHODS
Experimental solutions. Chemicals were purchased from Sigma except for CaCl 2 (Orion Research), propionic acid (Fluka), creatine phosphate (ICN), ATP (Roche), and CaM (Calbiochem). Solution compositions were calculated using the computer program of Fabiato (11) and the stability constants (corrected to pH 7.0 and 15°C) listed by Godt and Lindley (14) . Unless otherwise stated, all solutions contained (in mmol/l) 100 BES, 14.5 creatine phosphate, and 5 DTT. In addition, pCa 9.0 solution contained (in mmol/l) 7 EGTA, 0. Before the trabeculae were removed, each heart was exposed to fresh Ringer solution containing 30 mM BDM for 15 min to reduce RLC phosphorylation levels to close to 0%. This concentration of BDM was chosen because preliminary studies showed that lower concentrations failed to reduce RLC phosphorylation to Ͻ10%. The trabeculae were then transferred to relaxing solution [containing (in mmol/l) 100 KCl, 20 imidazole, 7 MgCl 2, 2 EGTA, 4 ATP, and 5 DTT; pH 7.0 at 4°C] containing 1% Triton X-100. After trabeculae were skinned for ϳ24 h, they were washed in fresh relaxing solution (1 h) and then stored at Ϫ20°C in relaxing solution containing glycerol [50:50 (vol/vol)]. The skinned trabeculae were used in experiments within 1 wk.
Attachment of preparations to experimental apparatus. On the day of an experiment, skinned trabeculae were washed in relaxing solution for 30 min before they were cut free from the sticks and their ends trimmed. The trimmed trabeculae were then transferred to a stainless steel experimental chamber (34) containing pCa 9.0 solution. The ends of each trabecula were attached to the arms of a motor (model 312B, Aurora Scientific) and force transducer (model 403, Aurora Scientific), as described earlier (34). The chamber assembly was then placed on the stage of an inverted microscope (Olympus) fitted with a ϫ40 objective and a CCTV camera (model WV-BL600, Panasonic). Filtered light (transmission Ͼ620 nm) from a halogen lamp was used to illuminate the skinned preparations. Bitmap images of the preparations were acquired using an AGP 4X/2X graphics card and associated software (ATI Technologies) and were used to assess mean sarcomere length during the course of each experiment. Changes in force and motor position were sampled (16-bit resolution, DAP5216a, Microstar Laboratories) at 2.0 kHz using SLControl software developed in this laboratory (http://www.slcontrol.com). Data were saved to computer files for later analysis.
Experimental design and protocol. At the start of each experiment, the skinned trabecula was stretched to a mean sarcomere length of ϳ2.35 m (15°C). First, steady-state force and ktr were measured simultaneously in Ca 2ϩ activating solution containing either submaximal (pCa 5.8 and 5.7) or saturating (pCa 4.5) [Ca 2ϩ ]free using the modified multistep protocol of Brenner and Eisenberg (6) described in detail previously (38) . These measurements yielded Ca 2ϩ sensitivities of force and ktr in BDM-treated (RLC dephosphorylated) skinned trabeculae. Next, the trabeculae were incubated for 10 min in preactivating solution containing 5 mM BDM (to inhibit force development); for 15 min in preactivating solution containing 5 mM BDM, 67 M CaCl2, 6 M CaM, and 0.43 M smMLCK (to phosphorylate RLC); and then for 30 min (3ϫ solution change) in pCa 9.0 solution (to wash out MLCK). Finally, force-pCa and ktr-pCa relationships were characterized.
Once mechanical measurements were finished, the trabeculae were cut free at the points of attachment, placed in denaturing sample buffer containing 8 M urea, 5% ␤-mercaptoethanol, 2% Triton X-100, and 2% carrier ampholytes (Pharmalyte pH 4.5-5.4, Amersham Pharmacia), and stored at Ϫ80°C until subsequent analysis of RLC phosphorylation by two-dimensional gel electrophoresis using a mini gel system (Bio-Rad). On the day that gels were run, the samples were allowed to warm to room temperature, sonicated for 20 min, and loaded onto polyacrylamide gels cast in capillary tubes (Bio-Rad). The first-dimension IEF tube gels contained 8 mol/l urea, 4% acrylamide-bisacrylamide (30% T:5.4% C), 2% Triton X-100 (pH 4.5-5.4), 2% ampholytes, 0.02% ammonium persulfate, and 0.2% TE-MED. The samples were electrofocused at 500 V for 15 min and 750 V for 3,600 V ⅐ h. Each IEF tube gel was placed on the top of a 12% SDS-PAGE slab gel and electrophoresed at 150 V (constant voltage) until dye ran off the end of the gel. Gels were then silver stained using methods described previously (43) . The percent RLC phosphorylation was quantified by scanning the gels using a densitometer (GDS-8000, UVP Bioimaging Systems) and accompanying software (Labworks UVP Bioimaging Systems).
Data analysis. Cross-sectional areas of skinned trabeculae were calculated by assuming that the trabeculae were cylindrical and by equating the width, measured from video images of the mounted preparations, to diameter. Each Ca 2ϩ -activated force (P) at pCa between 6.0 and 5.5 was expressed as a fraction of the maximum Ca 2ϩ -activated force (Po) developed by the same preparations at pCa 4.5, i.e., P/P o. To determine the Ca 2ϩ sensitivity of isometric force (pCa50), force-pCa data were fitted with the following Hill equation:
, where nH is the slope (Hill coefficient) and k is the Ca 2ϩ concentration for half-maximal activation (pCa50). ktr was determined by linear transformation of the half-time (t1/2) of force recovery [ktr ϭ Ϫln 0.5 ϫ (t1/2) Ϫ1 ], as described previously (7, 38) .
All data are presented as means Ϯ SE. Statistical analysis of the data was done using either paired or unpaired t-tests. P values Ͻ0.05 were taken as indicating significant differences.
RESULTS
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2ϩ sensitivity of force in BDM-, sham-, and MLCKtreated rat skinned trabeculae. All trabeculae used in these experiments were first treated with BDM to reduce RLC phosphorylation to near 0% and were then skinned for measurements of contractile properties and subsequent treatment with MLCK to assess the effects of RLC phosphorylation on contractile properties. As a control for MLCK treatment (i.e., incubation in preactivating solution containing Ca 2ϩ -CaMsmMLCK), some trabeculae were sham treated with identical solutions lacking Ca 2ϩ -CaM-smMLCK. To ensure that shamand MLCK-treated trabeculae had similar baseline contractile properties, force and k tr were measured at pCa 5.8, 5.7, and 4.5 before the sham or MLCK treatments. Statistical analysis using unpaired t-tests indicated that force and k tr were not significantly different in the trabeculae that were subsequently sham or MLCK treated ( Table 1 ). Force-pCa relationships from skinned trabeculae subjected to either sham or MLCK treatments were sigmoidal and were well fit with the Hill equation, as described in MATERIALS AND METHODS (Fig. 1) . pCa 50 , an index of Ca 2ϩ sensitivity of force, was significantly increased by MLCK treatment, from pCa 5.64 Ϯ 0.01 in sham-treated skinned trabeculae to pCa 5.70 Ϯ 0.01 after MLCK treatment. n H , an index of apparent cooperativity in the activation of force, was unchanged by MLCK treatment, i.e., n H was 5. Fig. 2 for both sham-treated (RLC dephosphorylated) and MLCKtreated trabeculae. Steady-state isometric force at each pCa was normalized to 1.0 to provide better visualization of the activation dependence of the kinetics of force redevelopment. The maximal values of k tr obtained at pCa 4.5 did not differ between sham-and MLCK-treated trabeculae (Table 1) , and the k tr -pCa relationships from these two treatment groups were virtually indistinguishable (Fig. 3A) . However, this finding does not mean that RLC phosphorylation had no effects on the kinetics of force development. Because RLC phosphorylation changes the relationship between steady-state force and [Ca 2ϩ ] free (Fig. 1) , comparisons of kinetics at similar forces might be more appropriate for assessing possible effects of activation. When k tr (normalized to maximum values in each preparation) was plotted versus steady isometric force (as a fraction of maximal force), k tr increased with force in both sham-and MLCK-treated trabeculae. However, MLCK treatment shifted the k tr -force relationship to the right of the relationship from sham-treated trabeculae, i.e., k tr at submaximal activations were slowed by MLCK treatment (Fig. 3B) . Thus when k tr was plotted against pCa, RLC phosphorylation appeared to have no effect on cross-bridge interaction kinetics, but when changes in Ca 2ϩ sensitivity are taken into account, RLC phosphorylation was found to slow k tr at submaximal activations.
As a control, k tr was measured during submaximal and maximal activations in skinned trabeculae before sham or MLCK treatment. Before treatment, all trabeculae displayed a similar increase in k tr from ϳ3 s Ϫ1 at pCa 5.8 to ϳ12 s Ϫ1 at pCa 4.5 (Table 1) .
RLC phosphorylation in sham-and MLCK-treated trabeculae. At the end of experiments on sham-and MLCK-treated trabeculae, each preparation was cut free at the points of attachment, placed in urea sample buffer, and stored at Ϫ80°C until subsequent analysis of RLC phosphorylation using twodimensional PAGE/IEF gels. In the examples shown in Fig. 4 , a sham-treated trabecula had 6% RLC phosphorylation (top) and a MLCK-treated trabecula had 50% RLC phosphorylation (bottom). Mean values for RLC phosphorylation were 7 Ϯ 1% of total RLC in sham-treated trabeculae and 58 Ϯ 4% of total RLC in MLCK-treated trabeculae (Table 1) .
DISCUSSION
In this study, the effects of basal levels of RLC phosphorylation on mechanical properties were assessed in cardiac skinned trabeculae in which BDM was used to reduce RLC phosphorylation from basal to very low levels. MLCK was then used to restore phosphorylation to approximately basal levels. Thus mechanical properties were measured before and after treatment in the same skinned trabecula so that each preparation served as its own control. The level of RLC phosphorylation was also measured in each trabecula after completion of the mechanical measurements. Increasing the level of phosphorylation from an average of ϳ7% to ϳ58% resulted in an increase in the Ca 2ϩ sensitivity of force, a small but significant increase in maximum force, and slowing of cross-bridge cycling kinetics at similar levels of submaximal activation. Thus it appears that basal level of RLC phosphorylation is an important determinant of the extent and kinetics of force development in mammalian ventricular myocardium. Effect of BDM on RLC phosphorylation. It is well established that under physiological conditions, the balance between MLCK-induced phosphorylation and phosphatase-induced dephosphorylation of RLC maintains a relatively constant level of RLC phosphorylation during the cardiac cycle. For example, in rat myocardium, ϳ40% of RLC is in the phosphorylated state (12, 31) . To understand the importance of this basal RLC phosphorylation in cardiac contraction, our experimental plan included a protocol to reduce RLC phosphorylation to near zero. This was achieved in our experiments with BDM, a compound that is thought to act as a "chemical phosphatase" (47) or as an agent with "phosphatase-like activity" (4) and has been shown to cause dephosphorylation of RLC in rat myocardium (45, 46) . In our studies on rat myocardium, treatment of trabeculae with BDM before they were skinned reduced RLC phosphorylation to an average of 7% of total RLC.
Effect of RLC phosphorylation on Ca 2ϩ sensitivity of force. Our observations that RLC phosphorylation increased both maximal force (by ϳ5%) and the Ca 2ϩ sensitivity of force (a leftward shift in the force-pCa relationship at all Ca 2ϩ concentrations; pCa 50 ϭ 0.06) with no effect on the slope of force-pCa relationship differ somewhat from some previous studies (30, 41) . Sweeney and Stull (41) reported that RLC phosphorylation had no significant effect on maximal force in rabbit myocardium and shifted the force-pCa relationship to the left at activations below but not above 50% maximal force, with a concomitant decrease in the slope of the force-pCa relationship. Morano et al. (30) studied Ca 2ϩ sensitivity of force in porcine skinned myocardium by measuring force at maximal and one submaximal [Ca 2ϩ ] and reported a 4.4% increase in maximal isometric force after MLCK treatment. This increase in maximal force did not reach statistical significance, potentially due to a reported large variability in Ca 2ϩ sensitivity between individual skinned preparations. The basis for the difference in results between studies is not known for certain, but there were significant differences in protocols and preparations. We studied rat skinned trabeculae with initial (post-BDM) phosphorylation levels of ϳ7% of total RLC, whereas Morano et al. (30) reported that ϳ46% of RLC in pig myocardium was phosphorylated before treatment with MLCK. Sweeney and Stull (41) reported that the RLC phosphorylation in rabbit skinned psoas muscle and myocardium was 5-10% before MLCK and 60 -75% after MLCK treatment. Unlike the present work, both of these earlier studies measured RLC phosphorylation on fibers different from those used in the mechanical studies.
Effects of RLC phosphorylation on activation dependence of k tr . Regardless of RLC phosphorylation levels, k tr in skinned trabeculae varied with the level of activating Ca 2ϩ (or force), increasing as Ca 2ϩ (or force) was increased from submaximal to maximal levels (Fig. 3) . These Ca 2ϩ -and force-dependent changes in k tr are consistent with previous results from rat living myocardium (3) and rat (13, 48) , mouse (38) , and guinea pig (36) skinned myocardium. Here, we also show that RLC phosphorylation (to an average of ϳ58% of total) has no significant effect on the k tr -pCa relationship in rat myocardium compared with trabeculae with near-zero (ϳ7%) RLC phosphorylation. However, the k tr -force relationship was shifted to the right such that MLCK-treated trabeculae redeveloped a given force at slower rate than trabeculae treated just with BDM. This lack of effect of RLC phosphorylation on the k tr -pCa relationship in rat skinned myocardium is consistent with an earlier report by Rossmanith et al. (39) showing that endothelin-induced RLC phosphorylation had no effect on rise time or relaxation time of twitch force in electrically paced myocardial preparations from the rat.
Both the present results and those of Rossmanith et al. (39) differ significantly from the effects of RLC phosphorylation on k tr in skinned skeletal muscle fibers reported earlier by Metzger et al. (24) and Sweeny and Stull (42) . In skeletal muscle fibers at intermediate levels of activation, but not at very low or at maximal activations, k tr was greater in MLCK-treated fibers. These groups also found that RLC phosphorylation increased force at low and intermediate [Ca 2ϩ ] but not at high [Ca 2ϩ ]. Thus RLC phosphorylation appears to speed the kinetics of myosin-actin interactions in skeletal muscle, whereas in cardiac muscle RLC phosphorylation has no effect on kinetics when expressed as a function of pCa but a slowing of kinetics when k tr is plotted against isometric force as an index of activation.
Possible mechanism of effects of RLC phosphorylation on mechanical properties. The effects of RLC phosphorylation on myocardial force can be explained by an increase in numbers of force-generating cross-bridges, force per cross-bridge, or both. In a simple two-state model (5, 15) , the cross-bridges cycle between a force-generating state and a nonforce-generating state, and the process is controlled by the rate constants f app (for the transition to the force-generating state) and g app (for the return to the non-force generating state (15) . The fraction of cycling cross-bridges in the force-generating state can be calculated as the ratio f app /(f app ϩ g app ), and steady-state isometric force (P) is given by P ϭ n ϫ F ϫ f app /(f app ϩ g app ), where n is the number of cycling cross-bridges and F is the mean force per cross-bridge (5). On the basis of this model, a RLC phosphorylation-mediated increase in Ca 2ϩ sensitivity of force in cardiac or skeletal muscles could be due to an increase in n or F or f app /(f app ϩ g app ). In skeletal muscle, phosphorylation of RLC had no significant effect on either n or F (42) but increased k tr (24, 42) . Because k tr ϭ f app ϩ g app , a straightforward explanation for an increase in k tr in skeletal muscle would be an increase in f app , which would also increase the ratio f app /(f app ϩ g app ) and hence force. In contrast, our data from cardiac muscle are consistent with a two-state model in which RLC phosphorylation increases maximum force and the Ca 2ϩ sensitivity of force and slows k tr by reducing the value of g app . Fig. 4 . Myosin regulatory light chain (RLC) phosphorylation in typical shamand MLCK-treated skinned trabeculae. RLC phosphorylation in trabeculae used for mechanical measurements was determined by two-dimensional SDS-PAGE/IEF of sham-treated and MLCK-treated preparations. In these examples, RLC phosphorylation was 6% of total RLC in the sham-treated trabecula and 50% of total RLC in the MLCK-treated trabecula.
In this regard, the effects of RLC phosphorylation on myocardial contraction are similar to the effects of increased MgADP, which also increases maximum force, increases Ca 2ϩ sensitivity of force, and slows the kinetics of force development (20, 21) . MgADP is thought to exert these effects by competing with MgATP for the nucleotide-binding pocket on myosin, thereby slowing cross-bridge detachment (9), relaxation from rigor (22) , relaxation from active contraction (19) , and overall cycling rate (17) . From these results in skeletal muscle, it is tempting to postulate that RLC phosphorylation in cardiac muscle prolongs attached states by influencing MgADP dissociation kinetics. However, high MgADP also slows unloaded shortening velocity (23) , whereas the effects of RLC phosphorylation on shortening velocity appear to be minimal (for a review, see Ref. 27) . A possible reason for this apparent discrepancy is that the effects of basal RLC phosphorylation on V max in striated muscles have yet to be fully characterized, particularly in cardiac muscle preparations. Enzymatically digested single cardiomyocytes may be the most reasonable cellular preparation to utilize, because larger myocardial preparations contain variable amounts of connective tissue, which may complicate the assessment of V max . However, several technical issues remain to be resolved with regard to single cardiomyocytes. First, Davis and co-workers (10) have demonstrated a transmural gradient in the level of RLC phosphorylation across the ventricular wall. Investigators would need to pinpoint the origin of the single cardiomyocyte (i.e., epicardium vs. endocardium) to avoid large variations in the basal level of RLC phosphorylation. Second, quantifying the level of RLC phosphorylation in a single cardiomyocyte using conventional electrophoretic techniques (e.g., isoelectric focusing) is technically challenging. Nevertheless, the ultimate experimental goal should involve measuring both V max and the level of RLC phosphorylation in the same single cardiomyocyte. It is also worth noting that RLC phosphorylation has been shown to slow the rate of relaxation of active force by up to threefold (37) , an observation that is consistent with modulation of cross-bridge detachment by phosphorylation. The detailed mechanisms underlying the effects of RLC phosphorylation on the regulatory and mechanical behavior of striated muscles and how these mechanisms might differ in skeletal and cardiac muscles remain to be fully elucidated.
Physiological significance of RLC phosphorylation. The basal level of RLC phosphorylation is likely to play a major role in defining the Ca 2ϩ sensitivity force under normal physiological condition. Because a large change (from ϳ7 to ϳ55%) in the level of RLC phosphorylation produces only a modest change in Ca 2ϩ sensitivity of force (pCa 50 ϭ 0.06), one would anticipate a much smaller alteration in Ca 2ϩ sensitivity of force with changes in the level of RLC phosphorylation that occurs in chronic endurance exercise of rats [from ϳ40 to ϳ55% (12)] or that observed in old spontaneously hypertensive rats [from ϳ40 to ϳ20% (31)] and hibernating European hamsters [from ϳ45 to ϳ20%; (28)], respectively. However, it is possible that only modest changes in the level of RLC phosphorylation are required to compensate adverse effects on Ca 2ϩ sensitivity of force that may occur under nonphysiological conditions, e.g., during acidosis, lack of Ca 2ϩ availability, and heart failure.
In summary, the overall influence of RLC phosphorylation on tension development kinetics appears to differ in cardiac and skeletal muscles. In skeletal muscle, the phosphorylationinduced increases in Ca 2ϩ sensitivity of force and in k tr have been interpreted in terms of a structural model in which RLC phosphorylation causes movement of myosin heads and increases the probability of interaction with actin (18, 24, 29) . Such a model does not account for an apparent decrease in g app due to RLC phosphorylation in cardiac muscle. Instead, the slowed kinetics of cross-bridge cycling in cardiac muscle suggests that RLC phosphorylation slows a state transition associated with cross-bridge detachment. This mechanism does not exclude the possibility that RLC phosphorylation increases f app in cardiac muscle, but the fact that cycling kinetics are slowed suggests that the effects of RLC phosphorylation to reduce g app are dominant. An additional difference between muscle types may be the level of RLC phosphorylation under basal conditions. The data presented here show that basal phosphorylation of ϳ50% of RLC in cardiac muscle is an important determinant of Ca 2ϩ sensitivity of force and the kinetics of force development.
